로그인 회원가입
icon_bulk_order대량 주문 Acrobiosystems for English
0
장바구니가 비어 있습니다
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: > TREM-1

TREM-1

요약

Name:Triggering receptor expressed on myeloid cells 1
Target Synonym:Triggering Receptor Expressed On Myeloid Cells 1,CD354 Antigen,Triggering Receptor Expressed on Myeloid Cells-1,TREM-1,TREM1,CD354,Triggering receptor expressed on monocytes 1
Number of Launched Drugs:0
Number of Drugs in Clinical Trials:4
Lastest Research Phase:Phase 2 Clinical

제품 리스트 구매

제품 상태별:
제품 유형별 :
종별:
태그별:
결합물별:
제품번호 제품 설명 구조 순도 특징
TR1-H5251 Human Human TREM-1 / CD354 Protein, Fc Tag
TR1-H5251-structure
TR1-H5251-sds

일부의 생물활성 데이터

TR1-H5251-BLI
 TREM-1 BLI

Loaded Human TREM-1, Fc Tag (Cat. No. TR1-H5251) on Protein A Biosensor, can bind Recombinant Human PGLYRP1/PGRP-S Protein, CF with an affinity constant of 18.5 nM as determined in BLI assay (ForteBio Octet Red96e) (Routinely tested).

TR1-H5251-ELISA
 TREM-1 ELISA

Immobilized Human TREM-1, Fc Tag (Cat. No. TR1-H5251) at 5 μg/mL (100 μL/well) can bind Recombinant Human PGLYRP1/PGRP-S Protein, CF with a linear range of 0.002-0.156 μg/mL (Routinely tested).

Synonym Name

TREM1,CD354

Background

Triggering receptor expressed on myeloid cells 1 (TREM1) is also known as CD antigen CD354, and is a type I transmembrane protein with a single Ig-like domain. TREM1 is highly expressed in adult liver, lung and spleen than in corresponding fetal tissue. TREM-1 / CD354 stimulates neutrophil and monocyte-mediated inflammatory responses, and also triggers release of pro-inflammatory chemokines and cytokines, as well as increased surface expression of cell activation markers. Amplifier of inflammatory responses that are triggered by bacterial and fungal infections and is a crucial mediator of septic shock. TREM1 can interacts with TYROBP / DAP12.

Clinical and Translational Updates

임상 약품 정보

Name Research Code Research Phase Company Indications Clinical Trials
Nangibotide LR-12 Phase 2 Clinical Inotrem Shock, Septic; Coronavirus Disease 2019 (COVID-19) Details
CEL383 CEL-383 Phase 1 Clinical Celsius Therapeutics Inc Inflammatory Bowel Diseases Details
TREM 1 antibody(Boehringer Ingelheim International Gmbh) TREM 1 antibody(Boehringer Ingelheim International Gmbh) Phase 1 Clinical Boehringer Ingelheim International Gmbh Immune System Diseases Details
PY-159 PY-159 Phase 1 Clinical Centre for the Commercialization of Antibodies and Biologics Solid tumours; Neoplasms Details
Nangibotide LR-12 Phase 2 Clinical Inotrem Shock, Septic; Coronavirus Disease 2019 (COVID-19) Details
CEL383 CEL-383 Phase 1 Clinical Celsius Therapeutics Inc Inflammatory Bowel Diseases Details
TREM 1 antibody(Boehringer Ingelheim International Gmbh) TREM 1 antibody(Boehringer Ingelheim International Gmbh) Phase 1 Clinical Boehringer Ingelheim International Gmbh Immune System Diseases Details
PY-159 PY-159 Phase 1 Clinical Centre for the Commercialization of Antibodies and Biologics Solid tumours; Neoplasms Details

This web search service is supported by Google Inc.

totop